U.S. Water Utilities Stock News

NasdaqGS:ONB
NasdaqGS:ONBBanks

Old National Bancorp (ONB) Earnings Growth Reinforces Bullish Narratives Despite Lower Net Margin

Old National Bancorp (ONB) just closed out FY 2025 with fourth quarter revenue of US$648.0 million and basic EPS of US$0.55, alongside trailing twelve month revenue of about US$2.3 billion and EPS of US$1.80. The bank has seen revenue move from US$458.4 million in Q4 2024 to US$648.0 million in Q4 2025, with basic EPS shifting from US$0.47 to US$0.55 over the same period, which sets the backdrop for how investors weigh its earnings profile. With a trailing net profit margin of 28.4% and a...
NYSE:HE
NYSE:HEElectric Utilities

Is Hawaiian Electric (HE) Pricing In Too Much Optimism After Its Recent Share Price Rebound

If you are wondering whether Hawaiian Electric Industries is attractively priced after a turbulent few years, you are not alone. The stock last closed at US$14.72, with returns of 4.9% over 7 days, 25.3% over 30 days, 16.5% year to date, but a 60.5% gain over 1 year sits against a 63.0% decline over 3 years and a 51.5% decline over 5 years. Recent market attention has focused on how investors are reassessing Hawaiian Electric Industries following past events and ongoing regulatory and...
NYSE:ALG
NYSE:ALGMachinery

Assessing Alamo Group (ALG) Valuation After Recent Share Price Momentum

Why Alamo Group stock is on investors’ radar Alamo Group (ALG) has moved onto investor watchlists after its recent share performance, with the stock around $191.95 and showing positive total returns over the past month and past 3 months. See our latest analysis for Alamo Group. That recent 11.38% 1 month share price return, alongside a 12.63% share price return year to date and a 5.15% total shareholder return over the past year, points to momentum that has been building rather than...
NasdaqGS:JKHY
NasdaqGS:JKHYDiversified Financial

Jack Henry Expands Instant Payments And Digital Assets As Valuation Stays Stretched

Jack Henry & Associates (NasdaqGS:JKHY) has launched Rapid Transfers, a cloud-native service for me-to-me payments, expanding its fintech capabilities for banks and credit unions. Coinbax has joined Jack Henry's Fintech Integration Network, adding support for compliant stablecoin transactions and programmable escrow for institutional clients. For investors watching how core banking providers respond to rising expectations for speed and convenience, these moves put a spotlight on where Jack...
NYSE:O
NYSE:ORetail REITs

Is It Too Late To Consider Realty Income (O) After Its Recent Share Price Rise?

Wondering whether Realty Income at around its recent US$61.79 close still offers value, or if most of the easy upside is already priced in? This article is built to help you frame that question clearly. The stock has returned 2.5% over the last 7 days, 9.0% over 30 days, 7.8% year to date and 21.1% over the last year, with total returns of 8.3% over 3 years and 36.0% over 5 years. This naturally raises questions about how its current price lines up against its fundamentals. Recent coverage...
NasdaqGS:FITB
NasdaqGS:FITBBanks

Fifth Third Bancorp (FITB) Net Interest Margin Stability Reinforces Bullish Narratives

Fifth Third Bancorp (FITB) has rounded out FY 2025 with fourth quarter revenue of US$2.2 billion and basic EPS of US$1.05, while trailing twelve month EPS sits at US$3.56 on revenue of US$8.4 billion and net income of US$2.4 billion. The company has seen revenue move from US$2.0 billion and EPS of US$0.86 in Q4 2024 to US$2.2 billion and EPS of US$1.05 in Q4 2025. On a trailing basis, revenue has shifted from US$8.0 billion and EPS of US$3.16 to US$8.4 billion and EPS of US$3.56, which may...
NasdaqGS:POWL
NasdaqGS:POWLElectrical

Is It Too Late To Consider Powell Industries (POWL) After Its Multi‑Year Share Price Surge?

If you are wondering whether Powell Industries at around US$421.85 is still offering value after a strong run, this article walks through what the current price might be implying. The stock has posted a 5.1% return over the last 7 days, 25.4% over the last 30 days, 19.7% year to date and 36.1% over the last year, with a very large return over 3 and 5 years that is well above 7x in both periods. Recent coverage around Powell Industries has focused on its share price strength and the attention...
NasdaqCM:OSW
NasdaqCM:OSWConsumer Services

Should OneSpaWorld (OSW) Investors Act on Updated 2025 Outlook and New 2026 Revenue Guidance?

In January 2026, OneSpaWorld Holdings Limited updated past guidance for the fourth quarter and full year 2025, slightly trimming its preliminary revenue ranges to about US$239.5 million–US$244.5 million for the quarter and US$958.5 million–US$963.5 million for the year, while also outlining expectations for year-over-year revenue growth. The company also issued fresh revenue guidance for fiscal 2026 of US$1.01 billion–US$1.03 billion, giving investors a clearer view of its anticipated scale...
NasdaqGM:APPN
NasdaqGM:APPNSoftware

Appian Brings AI Veteran David Link To Board As Shares Struggle

Appian has appointed David Link, CEO and co founder of ScienceLogic and a leader in AI driven IT operations, to its Board of Directors. Link brings experience in AI powered automation platforms and large scale enterprise deployments. The appointment is being viewed as an important move for Appian's focus on AI and automation software. Appian (NasdaqGM:APPN), trading at $28.41, has seen pressure on its share price with a 24.0% decline over the past month and a 16.6% decline year to date. The...
NasdaqGS:BBIO
NasdaqGS:BBIOBiotechs

How BridgeBio’s (BBIO) Convertible Notes and Attruby Uptake Have Changed Its Investment Story

In January 2026, BridgeBio Pharma, Inc. completed a US$550,000,000 Rule 144A offering of 0.75% senior unsecured convertible notes due February 1, 2033, following its earlier announcement of the deal. At the 44th Annual J.P. Morgan Healthcare Conference, the company also highlighted rapid uptake of its drug Attruby and ongoing progress at its oncology-focused spin-off, BridgeBio Oncology Therapeutics. We’ll now examine how BridgeBio’s successful convertible notes issuance and strong Attruby...
NYSE:VYX
NYSE:VYXSoftware

Is NCR Voyix (VYX) Quietly Rewiring Its Business Model Around Cloud Recurring Revenue?

Earlier this week at NRF’s Big Show 2026, NCR Voyix unveiled new applications for its Voyix Commerce Platform to help long-standing clients transition from legacy hardware to cloud-native systems with integrated payments. The move underscores NCR Voyix’s push toward higher-margin, recurring cloud revenue by simplifying retailers’ technology stacks into a unified commerce experience. We’ll now consider how this push toward integrated, recurring cloud services could shape NCR Voyix’s broader...
NasdaqGS:SPSC
NasdaqGS:SPSCSoftware

Did SPS Commerce’s New Supply Chain Cloud Tools Just Shift SPSC’s Investment Narrative?

In January 2026, SPS Commerce, Inc. announced a set of new supply chain products and capabilities, including SAP S/4HANA cloud connectivity, Shopify system automation, the SPS Relationship Center, and an enhanced Manufacturing Suite to improve visibility and coordination across complex, diversified supply networks. An important insight from this launch is how SPS Commerce is positioning its network and tools as a shared operating layer for retailers, manufacturers, and suppliers that need...
NasdaqGS:TTAN
NasdaqGS:TTANSoftware

Assessing ServiceTitan (TTAN) After Recent Share Price Slide And Mixed Valuation Signals

If you are wondering whether ServiceTitan shares at around US$88 are a bargain or just fairly priced, you are not alone. This article breaks down what that price could imply about the company’s value. The stock has seen a 9.2% decline over the last 7 days, a 20.2% decline over the last 30 days, and is down 13.3% year to date and 7.5% over the last year, which may have changed how some investors see its growth potential and risk profile. Recent attention on ServiceTitan has been driven by its...
NYSE:KRC
NYSE:KRCOffice REITs

A Look At Kilroy Realty (KRC) Valuation As Investors Reassess Office And Life Science REIT Prospects

Why Kilroy Realty is on investors’ radar today Kilroy Realty (KRC) has been drawing attention after a period of mixed share performance, with the stock showing a small 1 year total return but weaker moves over the past month and past 3 months. For a real estate investment trust focused on office and life science properties, those return figures invite a closer look at how its current valuation lines up with recent fundamentals, including revenue of about US$1.13b and net income of roughly...
NasdaqGS:XRX
NasdaqGS:XRXTech

Is Xerox (XRX) Using Its Lexmark AI Retail Suite to Redefine Its Competitive Moat?

In January 2026, Xerox Holdings and Lexmark, now a combined company, unveiled a unified suite of AI-enabled retail technology solutions at NRF 2026: Retail’s Big Show in New York, highlighting end-to-end offerings spanning IT, production print, digital workflows, signage, and vision AI for store operations. This collaboration underscores how integrating Xerox’s digital workflow and print capabilities with Lexmark’s retail-focused devices and vision AI can create a single platform that...
NYSE:LUMN
NYSE:LUMNTelecom

Has Lumen Technologies (LUMN) Run Too Far After Its Recent Share Price Rebound

If you are wondering whether Lumen Technologies at around US$8.39 still offers value or has already run too far, you are not alone. The stock shows returns of 2.2% over 7 days, 8.0% over 30 days, 9.1% year to date, 45.9% over 1 year and 58.3% over 3 years, while the 5 year return sits at a 36.9% decline. Recent attention on Lumen has been shaped by ongoing coverage of its turnaround efforts and balance sheet position, as investors weigh how the company responds to its debt load and industry...
NasdaqGS:ICLR
NasdaqGS:ICLRLife Sciences

Assessing ICON (ICLR) Valuation After Muted Share Performance And Mixed Pricing Signals

Event context and recent share performance ICON (NasdaqGS:ICLR) has drawn investor attention after a period of mixed share performance, with a small 1 day gain of 4.7% and broadly flat movement over the past week. Over the past month, the stock shows a 3.2% return, while the past 3 months reflect a 2.7% gain. The year to date figure and 1 year total return are both negative. See our latest analysis for ICON. With the share price at $184.87, ICON’s recent 4.7% 1 day share price return...
NasdaqGS:CRNX
NasdaqGS:CRNXPharmaceuticals

Is It Too Late To Consider Crinetics Pharmaceuticals (CRNX) After Strong Multi‑Year Share Gains?

Investors may be wondering if Crinetics Pharmaceuticals at around US$55.41 per share is still offering fair value, or if the recent excitement has already been priced in. The stock shows a flat 7 day return, while the 30 day return is 12.5%, year to date is 18.6%, and the 1 year return is 43.4%, with a very large 5 year gain of 282.9%. This performance may have changed how the market views its risk and potential. Recent coverage has focused on Crinetics Pharmaceuticals as a growth oriented...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

Is NetApp (NTAP) Starting To Look Attractive After The Recent Share Price Pullback?

If you are wondering whether NetApp at around US$97 per share still offers value, you are not alone. This article walks through what the current price might mean for long term investors. The stock has seen a 9.8% decline over the last 7 days and a 12.5% decline over the last 30 days, on top of an 8.8% decline year to date and a 21.4% decline over the last year, even though the 3 year and 5 year returns sit at 56.1% and 58.6% respectively. These moves have come alongside ongoing interest in...
NYSE:DCH
NYSE:DCHAuto Components

Assessing American Axle (AXL) Valuation After SAMSON ROCK CAPITAL’s Million Share Purchase

Institutional buying puts American Axle & Manufacturing Holdings (AXL) in focus SAMSON ROCK CAPITAL LLP has disclosed the purchase of more than 1 million American Axle & Manufacturing Holdings (AXL) shares, a move that brings fresh attention to the stock and its recent performance. See our latest analysis for American Axle & Manufacturing Holdings. The SAMSON ROCK CAPITAL LLP purchase comes as momentum in American Axle & Manufacturing Holdings has been picking up, with a 30 day share price...
NYSE:TEX
NYSE:TEXMachinery

Terex Elevates AI Leadership As Investors Weigh Margin And Growth Story

Terex Corporation (NYSE:TEX) has appointed Namita Jindal as Senior Vice President and Chief AI and Data Officer. Jindal will lead the company’s AI, data and broader digital transformation efforts. The new leadership role signals a company wide push to use data and automation across operations. Terex, a global manufacturer of lifting and material handling equipment, is increasing its focus on how software, data and connected machines fit alongside its core hardware business. Across...
NasdaqGS:WDFC
NasdaqGS:WDFCHousehold Products

Does WD-40 (WDFC) Reaffirmed Guidance Offset Softer Profits In Its Investment Story?

WD-40 Company recently reported first-quarter 2026 results, with sales of US$154.42 million edging above the prior year while net income and earnings per share were slightly lower, and the company also completed a share repurchase of 124,000 shares for US$28.19 million under its existing program. At the same time, management reaffirmed its fiscal 2026 guidance for higher full-year net sales, operating income, and diluted earnings per share compared with 2025 pro forma results, underscoring...
NYSE:COSO
NYSE:COSOBanks

CoastalSouth Bancshares (COSO) Q4 Net Interest Margin Supports Bullish Core Profitability Narrative

CoastalSouth Bancshares (COSO) has wrapped up FY 2025 with fourth quarter revenue of US$21.0 million and basic EPS of US$0.60, while trailing twelve month revenue and EPS came in at US$78.8 million and US$2.24 respectively. Over recent quarters the company has seen revenue move from US$18.0 million in Q1 2025 to US$21.0 million in Q4 2025, with quarterly EPS ranging between US$0.49 and US$0.60 over the same period. This gives investors a clearer view of the earnings base behind the latest...
NasdaqGS:ASND
NasdaqGS:ASNDBiotechs

Is Positive COACH Data and Priority Review for TransCon CNP Reframing Ascendis Pharma’s (ASND) Investment Case?

Earlier in January 2026, Ascendis Pharma A/S reported positive Week 52 topline Phase 2 COACH trial results for its once-weekly TransCon CNP and TransCon hGH combination in children with achondroplasia, alongside amending its Articles of Association to allow for new warrant grants. The COACH data highlighted durable growth, improved body proportionality, and a safety profile consistent with monotherapies, reinforcing TransCon CNP’s potential backbone role in treating achondroplasia as...